
United States Antimony (UAMY) is delivering a near-term operational turnaround with 160% YoY revenue growth in H1 2025 to $17.5M, nine‑month revenues of $26.2M (up 182%), gross profit up 183%, margins expanding from 24% to 28%, and cash/investments of $38.5M alongside minimal long-term debt as it restarts U.S. antimony mining at Stibnite Hill and expands processing capacity. The Metals Company (TMC) remains pre-revenue but well‑capitalized with $165M cash and over $400M potential from warrants, has published a PFS/IA with a combined NPV >$23B, advanced deep‑sea collection and onshore processing technology (battery‑grade manganese, nickel/cobalt sulfates), and is progressing regulatory and partner milestones toward potential commercial recovery in late 2027. Both firms support U.S. critical‑minerals security but present different risk/return profiles: UAMY offers immediate cashflow and production upside while TMC is long‑dated, capital‑intensive and dependent on regulatory permits and scale.
Market structure: Winners are domestic processors and defense-focused offtakers (UAMY, DLA contractors, downstream refiners such as Korea Zinc partners) that capture reshoring premiums; losers are high-cost foreign feedstock suppliers and speculative pure-exploration juniors without cash. UAMY’s H1 revenue +160% and $38.5m cash give true near-term optionality while TMC’s $165m cash and ~$23bn NPV underpin a binary long-dated play to 2027–2040 with large capex and regulatory exposure. Risk assessment: Tail risks include a seabed-permit moratorium or litigation (TMC) and a sharp antimony price collapse (>25% over 3 months) that would erase UAMY margin gains; operational failure (collector tech or furnace rebuild) is single-point failure. Time horizons: immediate (days–weeks) tradeable on momentum for UAMY, short-term (3–12 months) for exploration/cash runway signals, long-term (to Q4 2027+) for TMC permit/commercial start. Hidden dependencies: government contracting (DLA) is binary and can materially re-rate UAMY; partner/Allseas execution is critical for TMC. Trade implications: Tactical: establish a limited 2–3% long in UAMY (ticker UAMY) to capture 3–6 month production/assay catalysts, with a 30% stop-loss and take-profit at +50%; hedge with 3-month put if implied vol <80%. Strategic: build a 1% core long in TMCWW (ticker TMCWW) as a 24–36 month option on permits, scale to 3% only on permit certification or H1 2026 regulatory wins. Pair trade: long 2% UAMY / short 2% TMCWW for 1–3 months to capture near-term cash-flow vs long-dated binary premium compression. Contrarian angles: The market understates the ease of scaling UAMY’s processing economics — domestic military-spec antimony has higher gross margins and sticky demand, so upside could be >2x if DLA awards inventory contracts. Conversely, the seabed story may be over-discounting regulatory friction; historical parallel: rare-earth juniors (2010–2014) showed >80% drawdowns when permitting/tech timelines slipped. Unintended consequence: accelerated U.S. onshore supply could depress spot antimony prices, making small-margin explorers non-viable — size positions accordingly and prefer cash-rich operators.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.12
Ticker Sentiment